Civil Rights
Movements, leaders, victories and the continuing fight for equality.
Explore the people, places, events, achievements, struggles and stories that shaped our journey.
Movements, leaders, victories and the continuing fight for equality.
Innovation, patents, science, technology and world-changing contributions.
Pioneers, champions, Negro Leagues, records, activism and excellence.
Meet the people whose lives, choices and achievements shaped the journey.
Black towns, communities, institutions and places where history happened.
Moments that changed communities, movements, institutions and the nation.
Katherine Johnson’s mathematical calculations helped guide some of America’s most important early space missions while she confronted the racial and gender barriers faced by Black women in twentieth-century America.
MORE →Reflects the personal views, recollections, and perspective of the author, Mike Davis.
This is a personal recollection on the Move fire on May 13, 1985
This article may be too technical for most readers to understand. (August 2026) |
Chelation (/kiːˈleɪʃən/) is a type of bonding and sequestration of metal atoms. It involves two or more separate dative covalent bonds between a ligand and a single metal atom, thereby forming a ring structure.[1] The ligand is called a chelant, chelator, chelating agent, or sequestering agent. It is usually an organic compound, but this is not a requirement.
The word chelation is derived from Greek χηλή, chēlē, meaning "claw", because the ligand molecule or molecules hold the metal atom like the claws of a crab. The term chelate (/ˈkiːleɪt/) was first applied in 1920 by Sir Gilbert T. Morgan and H. D. K. Drew, who stated: "The adjective chelate, derived from the great claw or chele (Greek) of the crab or other crustaceans, is suggested for the caliper like groups which function as two associating units and fasten to the central atom so as to produce heterocyclic rings."[2]
Chelation is useful in the preparation of nutritional supplements, in chelation therapy to remove toxic metals from the body, as contrast agents in MRI scanning, in manufacturing using homogeneous catalysts, in chemical water treatment to assist in the removal of metals, and in fertilizers.

Bidentate ligands bind to metal ions forming a chelate ring. Ligands of higher denticity form two or more chelate rings. Ethylenediamine, 2,2'-bipyridine, and 1,10-phenanthroline form C2N2M chelate rings. Just like in organic chemistry, 5- and 6-membered chelate rings predominate.[3][4]

The chelate effect is the greater affinity of chelating ligands for a metal ion than that of similar nonchelating (monodentate) ligands for the same metal.
The thermodynamic principles underpinning the chelate effect are illustrated by the contrasting affinities of cadmium(II) for ethylenediamine (en) vs. methylamine.
| Cd2+ + en ⇌ [Cd(en)]2+ | 1 |
| Cd2+ + 2 MeNH2 ⇌ [Cd(MeNH2)2]2+ | 2 |
In (1) the ethylenediamine forms a chelate complex with the cadmium ion. Chelation results in the formation of a five-membered CdC2N2 ring. In (2) the bidentate ligand is replaced by two monodentate methylamine ligands of approximately the same donor power, indicating that the Cd–N bonds are approximately the same in the two reactions.
The thermodynamic approach to describing the chelate effect considers the equilibrium constant for the reaction: the larger the equilibrium constant, the higher the concentration of the complex.
| [Cd(en)] = β11[Cd][en] | 3 |
| [Cd(MeNH2)2] = β12[Cd][MeNH2]2 | 4 |
Electrical charges have been omitted for simplicity of notation. The square brackets indicate concentration, and the subscripts to the stability constants, β, indicate the stoichiometry of the complex. When the analytical concentration of methylamine is twice that of ethylenediamine and the concentration of copper is the same in both reactions, the concentration [Cd(en)] is much higher than the concentration [Cd(MeNH2)2] because β11 ≫ β12.
An equilibrium constant, K, is related to the standard Gibbs free energy, by
where R is the gas constant and T is the temperature in kelvins. is the standard enthalpy change of the reaction and is the standard entropy change.
Since the enthalpy should be approximately the same for the two reactions, the difference between the two stability constants is due to the effects of entropy. In equation (1) there are two particles on the left and one on the right, whereas in equation (2) there are three particles on the left and one on the right. This difference means that less entropy of disorder is lost when the chelate complex is formed with bidentate ligand than when the complex with monodentate ligands is formed. This is one of the factors contributing to the entropy difference. Other factors include solvation changes and ring formation. Some experimental data to illustrate the effect are shown in the following table.[5]
| Equilibrium | log β | | ||
|---|---|---|---|---|
| Cd2+ + 2 MeNH2 ⇌ Cd(MeNH2)22+ | 6.55 | −37.4 | −57.3 | 19.9 |
| Cd2+ + en ⇌ Cd(en)2+ | 10.62 | −60.67 | −56.48 | −4.19 |
These data confirm that the enthalpy changes are approximately equal for the two reactions and that the main reason for the greater stability of the chelate complex is the entropy term, which is much less unfavorable. In general it is difficult to account precisely for thermodynamic values in terms of changes in solution at the molecular level, but it is clear that the chelate effect is predominantly an effect of entropy.
Other explanations, including that of Schwarzenbach,[6] are discussed in Greenwood and Earnshaw (loc.cit).
Numerous biomolecules exhibit the ability to dissolve certain metal cations. Thus, proteins, polysaccharides, and polynucleic acids are excellent polydentate ligands for many metal ions. Organic compounds such as the amino acids glutamic acid and histidine, organic diacids such as malate, and polypeptides such as phytochelatin are also typical chelators. In addition to these adventitious chelators, several biomolecules are specifically produced to bind certain metals (see next section).[7][8][9][10]
Virtually all metalloenzymes feature metals that are chelated, usually to peptides or cofactors and prosthetic groups.[10] Such chelating agents include the porphyrin rings in hemoglobin and chlorophyll. Many microbial species produce water-soluble pigments that serve as chelating agents, termed siderophores. For example, species of Pseudomonas are known to secrete pyochelin and pyoverdine that bind iron. Enterobactin, produced by E. coli, is the strongest chelating agent known. The marine mussels use metal chelation, especially Fe3+ chelation with the Dopa residues in mussel foot protein-1 to improve the strength of the threads that they use to secure themselves to surfaces.[11][12][13]
In earth science, chemical weathering is attributed to organic chelating agents (e.g., peptides and sugars) that extract metal ions from minerals and rocks.[14] Most metal complexes in the environment and in nature are bound in some form of chelate ring (e.g., with a humic acid or a protein). Thus, metal chelates are relevant to the mobilization of metals in the soil, the uptake and the accumulation of metals into plants and microorganisms. Selective chelation of heavy metals is relevant to bioremediation (e.g., removal of 137Cs from radioactive waste).[15]
Synthetic chelates such as ethylenediaminetetraacetic acid (EDTA) proved too stable and not nutritionally viable. If the mineral was taken from the EDTA ligand, the ligand could not be used by the body and would be expelled. During the expulsion process, the EDTA ligand randomly chelated and stripped other minerals from the body.[16] According to the Association of American Feed Control Officials (AAFCO), a metal–amino acid chelate is defined as the product resulting from the reaction of metal ions from a soluble metal salt with amino acids, with a mole ratio in the range of 1–3 (preferably 2) moles of amino acids for one mole of metal.[citation needed] The average weight of the hydrolyzed amino acids must be approximately 150 and the resulting molecular weight of the chelate must not exceed 800 Da.[citation needed] Since the early development of these compounds, much more research has been conducted, and has been applied to human nutrition products in a similar manner to the animal nutrition experiments that pioneered the technology. Ferrous bis-glycinate is an example of one of these compounds that has been developed for human nutrition.[17]
Dentin adhesives were first designed and produced in the 1950s based on a co-monomer chelate with calcium on the surface of the tooth and generated very weak water-resistant chemical bonding (2–3 MPa).[18]
Chelation therapy is an antidote for poisoning by mercury, arsenic, and lead. Chelating agents convert these metal ions into a chemically and biochemically inert form that can be excreted. Chelation using sodium calcium edetate has been approved by the U.S. Food and Drug Administration (FDA) for serious cases of lead poisoning. It is not approved for treating "heavy metal toxicity".[19] Although beneficial in cases of serious lead poisoning, use of disodium EDTA (edetate disodium) instead of calcium disodium EDTA has resulted in fatalities due to hypocalcemia.[20] Disodium EDTA is not approved by the FDA for any use,[19] and all FDA-approved chelation therapy products require a prescription.[21]
Chelate complexes of gadolinium are often used as contrast agents in MRI scans, although iron particle and manganese chelate complexes have also been explored.[22][23] Bifunctional chelate complexes of zirconium, gallium, fluorine, copper, yttrium, bromine, or iodine are often used for conjugation to monoclonal antibodies for use in antibody-based PET imaging.[24] These chelate complexes often employ the usage of hexadentate ligands such as desferrioxamine B (DFO), according to Meijs et al.,[25] and the gadolinium complexes often employ the usage of octadentate ligands such as DTPA, according to Desreux et al.[26] Auranofin, a chelate complex of gold, is used in the treatment of rheumatoid arthritis, and penicillamine, which forms chelate complexes of copper, is used in the treatment of Wilson's disease and cystinuria, as well as refractory rheumatoid arthritis.[27][28]
Chelation in the intestinal tract is a cause of numerous interactions between drugs and metal ions (also known as "minerals" in nutrition). As examples, antibiotic drugs of the tetracycline and quinolone families are chelators of Fe2+, Ca2+, and Mg2+ ions.[29][30]
EDTA, which binds to calcium, is used to alleviate the hypercalcemia that often results from band keratopathy. The calcium may then be removed from the cornea, allowing for some increase in clarity of vision for the patient.[31][32]
Homogeneous catalysts are often chelated complexes. A representative example is the use of BINAP (a bidentate phosphine) in Noyori asymmetric hydrogenation and asymmetric isomerization. The latter has the practical use of manufacture of synthetic (–)-menthol.
A chelating agent is the main component of some rust removal formulations. Citric acid is used to soften water in soaps and laundry detergents. A common synthetic chelator is EDTA. Phosphonates are also well-known chelating agents. Chelators are used in water treatment programs and specifically in steam engineering.[citation needed] Although the treatment is often referred to as "softening", chelation has little effect on the water's mineral content, other than to make it soluble and lower the water's pH level.
Metal chelate compounds are common components of fertilizers to provide micronutrients. These micronutrients (manganese, iron, zinc, copper) are required for the health of the plants. Most fertilizers contain phosphate salts that, in the absence of chelating agents, typically convert these metal ions into insoluble solids that are of no nutritional value to the plants. EDTA is the typical chelating agent that keeps these metal ions in a soluble form.[33]
Because of their wide needs, the overall chelating agents growth was 4% annually during 2009–2014[34] and the trend is likely to increase. Aminopolycarboxylic acids chelators are the most widely consumed chelating agents; however, the percentage of the greener alternative chelators in this category continues to grow.[35] The consumption of traditional aminopolycarboxylates chelators, in particular the EDTA (ethylenediaminetetraacetic acid) and NTA (nitrilotriacetic acid), is declining (−6% annually), because of the persisting concerns over their toxicity and negative environmental impact.[34] In 2013, these greener alternative chelants represented approximately 15% of the total aminopolycarboxylic acids demand. This is expected to rise to around 21% by 2018, replacing and aminophosphonic acids used in cleaning applications.[36][35][34] Examples of some Greener alternative chelating agents include ethylenediamine disuccinic acid (EDDS), polyaspartic acid (PASA), methylglycinediacetic acid (MGDA), glutamic diacetic acid (L-GLDA), citrate, gluconic acid, amino acids, plant extracts etc.[35][37]
Dechelation (or de-chelation) is a reverse process of the chelation in which the chelating agent is recovered by acidifying solution with a mineral acid to form a precipitate.[38]: 7
This article incorporates text by Kaana Asemave available under the CC BY 4.0 license.
Source: Wikipedia. Article content is retrieved live through the MediaWiki API.
Chelation () is a type of bonding and sequestration of metal atoms. It involves two or more separate dative covalent bonds between a ligand and a single metal atom, thereby forming a ring structure. The ligand is called a chelant, chelator, chelating agent, or sequestering agent. It is usually an organic compound, but this is not a requirement. The word chelation is derived from Greek χηλή, chēlē, meaning "claw", because the ligand molecule or molecules hold the metal atom like the claws of a crab. The term chelate () was first applied in 1920 by Sir Gilbert T. Morgan and H. D. K. Drew, who stated: "The adjective chelate, derived from the great claw or chele (Greek) of the crab or other crustaceans, is suggested for the caliper like groups which function as two associating units and fasten to the central atom so as to produce heterocyclic rings." Chelation is useful in the preparation of nutritional supplements, in chelation therapy to remove toxic metals from the body, as contrast agents in MRI scanning, in manufacturing using homogeneous catalysts, in chemical water treatment to assist in the removal of metals, and in fertilizers.
Chelation therapy is a medical procedure that involves the administration of chelating agents to remove heavy metals from the body. Chelation therapy has a long history of use in clinical toxicology and remains in use for some very specific medical treatments, although it is administered under very careful medical supervision due to various inherent risks, including the mobilization of mercury and other metals through the brain and other parts of the body by the use of weak chelating agents that unbind with metals before elimination, exacerbating existing damage. To avoid mobilization, some practitioners of chelation use strong chelators, such as selenium, taken at low doses over a long period of time. Chelation therapy also has a history of fraudulent use in alternative medicine, to treat claimed effects of heavy-metal exposure on problems as disparate as heart disease, cancer, and autism. Chelation therapy must be administered with care as it has a number of possible side effects, including death. In response to increasing use of chelation therapy as alternative medicine and in circumstances in which the therapy should not be used in conventional medicine, various health organizations have confirmed that medical evidence does not support the effectiveness of chelation therapy for any purpose other than the treatment of heavy metal poisoning. Over-the-counter chelation products are not approved for sale in the United States.
Chelation therapy for autism is a controversial and potentially harmful intervention based on the unproven hypothesis that autism is caused by heavy metal poisoning, particularly from mercury or lead. It is sometimes promoted as a treatment to improve behavior or cure autism, despite the lack of scientific evidence supporting its effectiveness. Chelation therapy was widely promoted in the United States before 2010 by proponents of the Defeat Autism Now! movement, particularly among holistic practitioners. In 2005, the death of an autistic child undergoing this treatment led the National Institute of Mental Health (NIMH) to suspend a clinical trial for ethical reasons. A 2013 literature review found no evidence supporting the efficacy of chelation for autistic individuals. In France, warnings regarding the use of this treatment began to be issued in 2011. Chelation therapy is associated with multiple adverse effects, including liver dysfunction, kidney damage, and hypocalcemia. Due to its unfavorable risk–benefit ratio, several health authorities and organizations, including the Cochrane Collaboration, the Haute Autorité de santé (HAS), and the Agence nationale de sécurité du médicament et des produits de santé (ANSM), have issued recommendations against its use in the treatment of autism.
Lead poisoning, also known as plumbism and saturnism, is a type of metal poisoning caused by the presence of lead in the human body. Symptoms of lead poisoning may include abdominal pain, constipation, headaches, irritability, memory problems, infertility, numbness and tingling in the hands and feet. Some of the effects are permanent. In severe cases, anemia, seizures, coma, or death may occur. Chronic lead poisoning occurs due to prolonged exposure. Exposure to lead can occur through contaminated air, water, dust, food, or consumer products. Lead poisoning poses a significantly increased risk to children and pets as they are far more likely to ingest lead indirectly by chewing on toys or other objects that are coated in lead paint. Additionally, children absorb greater quantities of lead from ingested sources than adults. Exposure at work is a common cause of lead poisoning in adults, with certain occupations at particular risk. Diagnosis is typically by measurement of the blood lead level. The Centers for Disease Control and Prevention (US) has set the upper limit for blood lead for adults at 10 μg/dL (10 μg/100 g) and for children at 3.5 μg/dL; before October 2021 the limit for children was 5 μg/dL. Elevated lead may also be detected by changes in red blood cells or dense lines in the bones of children as seen on X-ray. Lead poisoning is preventable. Prevention strategies include individual efforts such as removing lead-containing items from the home, workplace efforts such as improved ventilation and monitoring, state and national policies that ban lead in consumer products such as paint, gasoline, ammunition, wheel weights, and fishing weights, reduce allowable levels in water or soil, and provide for cleanup of contaminated soil. Workers' education could be helpful as well. The major treatments are removal of the source of lead and the use of medications that bind lead so it can be eliminated from the body, known as chelation therapy. Chelation therapy in children is recommended when blood levels are greater than 40–45 μg/dL. Medications used include dimercaprol, edetate calcium disodium, and succimer. With chronic lead poisoning causing millions of deaths per year and brain damage in millions of children, the burden of lead poisoning on the worldwide population is immense. The World Health Organization has described chronic lead exposure and poisoning as a worldwide public health emergency, with urgent interventions needed to reduce exposure to lead and improving health systems' capicity to screen for and treat lead poisoning. In 2019, 5.5 million deaths worldwide were attributed to cardiovascular disease caused by lead poisoning. Chronic lead poisoning is a leading contributor to intellectual disability, learning disabilites, and behavioral problems in children. Lead poisoning causes an estimated 30% of intellectual disability of otherwise unknown cause. Every year, lead poisoning causes a loss of 765 million IQ points in children. The global disease burden of deaths from lead poisoning and intellectual disabilities in children was estimated at 6.0 trillion dollars during 2019 (or 7% of the worldwide gross domestic product). Lead poisoning occurs most commonly in the developing world. An estimated 800 million children have blood lead levels over 5 μg/dL in low- and middle-income nations, though comprehensive public health data remains inadequate. Those who are poor are at greater risk. Lead is believed to result in 0.6% of the world's disease burden. Globally, over 15% of children are known to have blood lead levels (BLL) of over 10 μg/dL, at which point clinical intervention is strongly indicated. People have been mining and using lead for thousands of years. Descriptions of lead poisoning date to at least 200 BC, while efforts to limit lead's use date back to at least the 16th century. Human exposure to lead increased significantly during the 20th century, when industrialization led to lead being used in a variety of industrial processes and household products. Public health efforts to limit exposure to lead began in the 1970s, when it became understood that due to its bioaccumulative nature, there was no safe threshold for lead exposure. Humans have 100 times more lead in their bodies as compared to humans in pre-industrialized times. However, efforts to reduce lead exposure (such as the worldwide banning of leaded gasoline) have lead to a 95% reduction in humans' lead levels since the 1970s in some countries (such as the United States).
Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.
MORE →Shirley Chisholm, elected in 1968.